GLP Watchdog

altRX vs Zealthy

altRX has an open FDA warning letter dated June 8, 2026. Zealthy has an open FDA warning letter dated September 9, 2025. No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

altRX / Zealthy

Featured pick (affiliate partner)

altRX logo

altRX

8.8/10

Zealthy logo

Zealthy

5.6/10

FDA warning letters
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
None named in our record
Lowest standing price
$89/moCompounded semaglutide injection
$286/moCompounded semaglutide injection, medication only, membership extra
States
All 50 states
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit altRX
Visit Zealthy

altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Zealthy pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Zealthy 5.6). How we are paid

What the record shows

  1. 01

    altRX has an open FDA warning letter dated June 8, 2026. Zealthy has an open FDA warning letter dated September 9, 2025.

  2. 02

    altRX names four pharmacies. Zealthy names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top.

  4. 04

    Only altRX lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

altRX

Zealthy

Compounded semaglutide injection

$89/mo

$1,068 a year

$286/mo

medication only, membership extra; not compared

Compounded tirzepatide injection

$149/mo

$1,788 a year

$351/mo

medication only, membership extra; not compared

Brand-name semaglutide pen

$1,149/mo

$13,788 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,249/mo

$14,988 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; multi-month plans are prepaid and non-refundable
Monthly membership that renews automatically; quarterly, semi-annual and annual memberships are also sold
Refunds
All payments are final and non-refundable, except a partial refund if you are medically disqualified
Medication, consultation and membership charges are non-refundable

Read off each seller’s own pages. altRX: September 28, 2026. Zealthy: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for altRX

8.8/10
Featured pick (affiliate partner)
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Zealthy does not price
  • Names its compounding pharmacy
  • Open FDA warning letter, June 8, 2026
Visit altRX

The case for Zealthy

5.6/10

The record gives Zealthy no edge on this pair.

  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
  • Lowest price covers the medication only, with a separate membership on top
Visit Zealthy

Scores

altRX 8.8 · Zealthy 5.6 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
2.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

altRX vs Zealthy: questions

altRX has an open FDA warning letter dated June 8, 2026. Zealthy has an open FDA warning letter dated September 9, 2025. Letters are matched to a seller by company, domain and address, never by a similar name.
altRX names four pharmacies. Zealthy names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
altRX states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified. Zealthy states you can cancel at any time; refunds: medication, consultation and membership charges are non-refundable.
altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Zealthy pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Zealthy 5.6).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks